Do you offer adjuvant bisphosphonates to high-risk premenopausal women on ovarian suppression for early-stage breast cancer who would want to consider pregnancy in the future?  

Which agents would you select and for how long would you treat them?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice